Dyslipidemia Drugs Market Size, Share & Industry Analysis, By Drug Class (Statins, PCSK9 Inhibitors, Cholesterol Absorption Inhibitors, Fibrates, Prescription Omega-3 Therapies, ATP Citrate Lyase Inhibitors, & Others), By Disease Indication (Mixed Dyslipidemia, Primary/Familial Hypercholesterolemia, Established Cardiovascular Disease, Diabetes/Metabolic Syndrome-associated Dyslipidemia, and Others), By Age Group, By Route of Administration (Oral, Subcutaneous, & Others), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail or Online Pharmacies), & Regional Forecast, 2026-2034